ATAI ATAI Life Sciences N.V. - 8-K - (2025-11-05)

Form 8-K Summary: Atai Beckley N.V.

The Company filed a prospectus supplement covering the resale of up to 5,316,238 common shares of ATAI.

These shares are being registered to satisfy registration rights granted to selling securityholders in connection with the Company’s acquisition of the remaining shares of Beckley Psytech Limited.

...

Join thousands of investors who never miss important market updates

Join